Brixton Biosciences Nabs $33M to Advance Novel Pain Therapies

Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by...

Related Keywords

Massachusetts ,United States ,Sameer Sabir ,Brixton Biosciences ,Michael Fishman ,Sv Health Investors ,Catalyst Health Ventures ,Sparta Group ,Centric Pain Solutions ,Medtronic ,Brixton Biosciences Secures ,Advance Novel Pain Therapies ,Chief Executive Officer ,Should Know ,Schooner Capital ,Excelestar Ventures ,Catalyst Health ,Chief Medical ,Reggie Groves ,Pioneering Patient Centric Pain ,Massachusetts General Brigham ,Neural Ice ,Biosciences Secures ,Breakthrough Device Designation ,